inTest is trading 10.2% lower at $13.50 in pre-market, and no specific overnight catalyst explaining the decline has been identified.
- The shares closed at $15.04 on October 5.
- Preliminary third-quarter orders are expected to reach a record $48 million to $50 million, with revenue at the high end of guidance.
- The company expects to report final results on November 6.